相关实验视频
Updated: Jul 20, 2025
06:33
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
7.8K
[转基因氨基氨基酸心肌病]
1Klinik für Kardiologie und Pneumologie, Universitätsmedizin Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Deutschland. f.czepluch@med.uni-goettingen.de.
Innere Medizin (Heidelberg, Germany)
|August 4, 2023
概括
晶胺氨基酸心肌病变 (ATTR-CM) 是一个被诊断不足的心力衰竭的原因. 早期诊断和tafamidis的治疗可以显著延迟疾病的进展.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 内部医学 内部医学
背景情况:
- 晶胺氨基酸心肌病变 (ATTR-CM) 是心力衰竭的渐进和未被确诊的原因.
- 在患有左心室缩 (LVH),心力衰竭与保留射出分数 (HFpEF) 或大动脉狭窄的老年患者中考虑ATTR-CM.
- ATTR-CM是由遗传变异或衰老引起的,导致粉样纤维的积累和限制性心肌病.
研究的目的:
- 强调在特定患者群体中考虑ATTR-CM的重要性.
- 概述ATTR-CM的诊断方法.
- 讨论ATTR-CM的当前和新兴治疗策略.
主要方法:
- 对ATTR-CM的临床表现,诊断标准和治疗选择的审查.
- 强调非侵入性诊断方法,如骨光学和排除单克隆蛋白质.
- 讨论tafamidis作为TTR稳定剂以及潜在的未来疗法.
主要成果:
- ATTR-CM表现为心力衰竭症状,导电障碍,并可能与手掌道综合征等心脏外表现有关.
- 诊断可以通过心肌活检或通过骨扫描进行非侵入性诊断.
- 塔法米迪斯在延缓疾病进展方面表现出有效性.
结论:
- ATTR-CM需要增加临床怀疑,特别是在患有LVH和HFpEF的老年患者中.
- 非侵入性诊断是可行的,对于及时干预至关重要.
- 使用TTR稳定剂的向治疗提供了一种有希望的方法来管理ATTR-CM.
相关概念视频
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
01:30Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
01:25Cardiomyopathy I: Introduction and Classification
15
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
15
01:29Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
03:03Amyloid Fibrils
5.5K
5.5K